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Innate humoral immune defences in mammals and insects: The same, with
differences ?
Gerard Sheehan, Amy Garvey, Michael Croke, and Kevin Kavanagh
Department of Biology, Maynooth University, Maynooth, Ireland
ABSTRACT
The insect immune response demonstrates many similarities to the innate immune response of
mammals and a wide range of insects is now employed to assess the virulence of pathogens and
produce results comparable to those obtained using mammals. Many of the humoral responses in
insects and mammals are similar (e.g. insect transglutaminases and human clotting factor XIIIa)
however a number show distinct differences. For example in mammals, melanization plays a role
in protection from solar radiation and in skin and hair pigmentation. In contrast, insect melaniza-
tion acts as a defence mechanism in which the proPO system is activated upon pathogen
invasion. Human and insect antimicrobial peptides share distinct structural and functional simila-
rities, insects produce the majority of their AMPs from the fat body while mammals rely on
production locally at the site of infection by epithelial/mucosal cells. Understanding the structure
and function of the insect immune system and the similarities with the innate immune response
of mammals will increase the attractiveness of using insects as in vivo models for studying host –
pathogen interactions.
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Introduction
The innate immune system is the first line of defence
against invading pathogens in both insects and mam-
mals. Although innate immune responses are non-
specific, they are widely distributed throughout the
body allowing them to play a crucial role in the
maintenance of homeostasis and the prevention of
disease and infection [1]. The insect and mammalian
innate immune systems consist of humoral and cel-
lular responses. The cellular response is mediated by
hemocytes in insects and myeloid cells in mammals
and involves the targeting of pathogens through pro-
cesses such as phagocytosis, superoxide production,
encapsulation and enzyme release. Insect hemocytes
display many structural and functional similarities to
neutrophils of the mammalian immune response [2–
4]. Insect and mammalian humoral responses involve
processes such as melanization, clotting and the
secretion of antimicrobial peptides. In addition,
mammals also possess an adaptive immune system
which first evolved in jawed fish 500 million years
ago after the divergence of vertebrates and inverte-
brates [5]. The adaptive immune system enables a
specific response to a pathogen and relies upon the
presence of lymphocytes with specific receptors that
recognize pathogenic antigens. The adaptive immune
system also has the ability to remember previous
pathogen attacks, resulting in a more effective
immune response to subsequent infection [6]. While
insects do not have an adaptive immune response
they display immunological priming as a result of
prior exposure which enhances survival to a subse-
quent insult as a result of increased humoral and
cellular responses [4,7,8].
A wide range of insects is now employed to
study the virulence of medically important patho-
gens and this is made possible by the similarities
between the insect immune response and the mam-
malian innate immune responses. Insects such as
Drosophila melanogaster [9–11], Galleria mellonella
[12–15], Manduca sexta [16,17], and Bombyx mori
[18] are now widely used to overcome the disad-
vantages associated with testing in mammalian sys-
tems (e.g. cost, housing, legal/ethical restrictions)
while generating comparable results. This develop-
ment has accelerated research and lead to a reduc-
tion in cost and in the use of mammals for these
types of experiments [19–22]. This review compares
the humoral immune response of insects and mam-
mals and demonstrates how these can be exploited
to validate the use of insects as alternatives to the
use of mammals.
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Humoral immune signalling pathways in
mammals and insects
The Toll and Toll-like pathway
Toll-like receptors (TLRs) are a group of type I transmem-
brane receptors that play a role in innate humoral immu-
nity in both insects and mammals. As Toll and TLRs are
conserved throughout evolution, they can be found in
mammals, invertebrates and plants. Homologies between
these receptors can be observed between the cytoplasmic
Toll/IL-1R (TIR) domain of both mammalian Toll-like
receptors and the Drosophilia Toll receptor. In addition
to a TIR cytoplasmic domain, toll receptors can be char-
acterized by an extracellular domain consisting of several
leucine-rich repeats (LRRs) [23]. Despite the conservation
of these domains in mammals and insects there are some
structural and functional differences observed in the indi-
vidual Toll receptors and genes. Structurally, mammalian
Toll-like receptors contain one cysteine cluster at the
C-terminal domain of their LRRs while insects contain
multiple cysteine clusters on both the C-terminal and
N-terminal domains of their LRRs [24]. Functionally, the
Toll genes are vital in Drosophilia embryogenesis where
they are involved in dorsal-ventral development. Insect
Toll-signalling is also essential in the production of AMPs
in response to pathogen invasion, in particular antifungal
peptides such as drosomycin, highlighting its role in innate
humoral immunity [25]. Conversely, mammalian Toll-like
genes are involved in the production of cytokines and co-
stimulatory molecules upon pathogen recognition. The
production of these molecules results in the activation of
T-lymphocytes, thereby linking themammalian innate and
adaptive immune responses [26].
Upon activation of Toll and Toll-like receptors a
series of similar signalling pathways is initiated in
insects and mammals which lead to activation of homo-
logous transcription factors; NF-κB in mammals and
Dorsal and Dif in insects (Figure 1). These transcrip-
tion factors are responsible for the resulting anti-micro-
bial response in both animal groups [27]. Toll pathway
activation in mammals occurs directly through binding
of microbial associated material to their specific Toll
receptor. In insects, activation occurs indirectly where
microbial invasion induces the production of a
cysteine-knot protein called Spätzle which can bind to
Toll receptors [28]. Upon Drosophilia Toll activation by
Spätzle the adaptor protein myeloid differentiation pri-
mary response protein (MyD88) is recruited to the TIR
domain of the Toll receptor. A hetero-trimeric complex
is formed with MyD88, the kinase Pelle and the protein
Tube. As a result of Pelle activation, the inhibitor
protein Cactus is phosphorylated and degraded. In its
Figure 1. Diagramatic representation of the similarities between invertebrate Toll signalling and vertebrate toll-like signalling.
Upon activation of invertebrate toll receptor and the homologous toll-like receptor in vertebrates, a cascade is induced where the
homologous transciption facotors Nf-κB and Dif are activated in vertebrates and invertebrates, respectively. Upon translocation of these
transcription factors, AMPs are produced in invertebrates while co-stimulatory molecules and pro-inflammatory cytokines such as IL-1β, IL-6
and IL-8 are produced in vertebrates.
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inactive form Cactus is bound to the transcription
factors Dif or Dorsal. Therefore, upon Cactus degrada-
tion Dorsal or Dif are free to translocate to the nucleus
resulting in the transcription of anti-fungal AMPs [29].
A very similar proccess occurs in mammalian Toll-like
signalling (Figure 1). In mammals, upon binding of
microbial derived material such as peptidoglycan or
lipopolysaccharide to Toll-like receptor MyD88, which
is homologous to Drosophila MyD88, is recruited to the
TIR domain. This initiates the recruitment of IRAK
kinases which are homologous to Drosophila Pelle and
Tube. Kinase activation results in the phosphorylation
and degradation of I-κβ, which is homologous to
Drosophila Cactus, thereby initiating the translocation
of the now unbound NF-κB (homologous to Drosophila
Dif and Dorsal) to the nucleus for transcription of co-
stimulatory molecules, cytokines and chemokines [30].
The IMD and TNF-α signalling pathways
In addition to Toll signalling, Drosophilia can induce
the IMD signalling pathway to produce AMPs. The
IMD pathway recognizes components of the bacterial
cell wall such as peptidoglycan, resulting in the activa-
tion of a cascade that ultimately produces AMPs. The
IMD pathway displays some similiarities to the mam-
malian tumour necrosis factor-α (TNF-α) pathway as
well as the Toll-like pathway. Both the TNF-α and IMD
pathways ultimately result in the production of the
homologous transcription factors NF-κB and Relish,
respectively (Figure 2). In insects, the IMD pathway is
initiated by binding of peptidoglycan to peptidoglycan-
recognition proteins (PGRPs) while in mammals, the
TNF-α pathway is initiated through the binding of
TNF-α to tumor necrosis factor receptor 1 (TNFR1)
[31,32]. Peptidoglycan recognition in Drosophila results
in the recruitment of IMD, a death domain protein, the
adaptor protein dFADD, and DREDD to form a com-
plex. The activation of this complex promotes the cle-
vage of IMD from the complex and activation of the
Drosophila TAB2/TAK1 complex. As a result, the
Drosophila IKK complex is activated and phosphory-
lates Relish. Rel-68, the N-terminal domain of Relish,
can then translocate to the nucleus and initiate the
production of anti-bacterial AMPs such as diptericin
[33]. Conversely, TNFR1 activation in mammals initi-
ates the recruitment of RIPP, FADD and caspase 8
which are homologous to Drosophila IMD, dFADD
and DREDD, respectively. The formation of the RIPP/
FADD/caspase 8 complex activates TAK1 (homologous
Figure 2. Comparision of insect IMD pathway and mammalian TNF-α pathway.
The IMD pathway is activated by binding of peptidoglycan (PGN) to peptidoglycan-recognition proteins (PGRPs) which results in recruitment
and formation of a IMD, dFADD and DREDD complex and results in IMD cleavage and subseqeunt activation of TAB2/TAK1. This results in
Relish phosphorylation and ultimately the production of AMPs (e.g cecropin). Alternatively in mammals, TNF-α is bound by the tumor
necrosis factor receptor 1 (TNF-R1) which results in recuirment of RIPP, FADD and caspase 8. This complex activates TAK1 which activates
the IKK complex resulting in phosphoylation and degradation of the inhibitor protein IκB. NF-κB is released for translocation to the nucleus
resulting in pro-inflammatory cytokine production.
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to Drosophila TAK1). TAK1 activates the IKK complex
(homologous to Drosophila IKK complex) which phos-
phoylates and degrades the inhibitor protein IκB. Upon
IκB degradation, NF-κB is released for translocation to
the nucleus [34]. In mammals, TNF pathways are
involved in the production of pro-inflammatory cyto-
kines as well as cell survival and apoptosis pathways,
therefore also linking the innate and adaptive immune
responses [35].
The blood/hemolymph clotting system in
insects and mammals
The role of clotting systems
Clotting is an essential component of the innate immune
systemandpromotes hemostasis by inducing the formation
of an insoluble matrix/clot in the insect hemolymph or
mammalian blood. The formation of a clot also aids in
the sealing of wounds and prevention of pathogen entry
and infection [36]. Due to insects having an open circula-
tory system, clotting plays a vital role in the insect immune
system. The insect clotting system is extremely efficient in
order to prevent loss of hemolymph and the spread of
infection, and for hemocoel compartmentalisation.
Additionally, clotting helps to limit potential tissue damage
caused by other immune responses by localising activity to
wounding/pathogen entry sites. In contrast,mammals have
a closed circulatory system and an adaptive immune
response which lessens their reliance on such an efficient
clotting system, especially since thrombosis (clot forma-
tion) is costly [37].
Similarities between insect and mammalian
clotting factors
Similarities between insect and mammalian clotting
cascades can be observed in the family of transglutami-
nases which are involved in the hardening of a clot.
Insect transglutaminases are homologous to human
clotting factor XIIIa; one of eight transglutaminases
found in humans. Factor XIIIa is involved in the final
hardening of the clot in humans while insect transglu-
taminase is believed to contribute to the clotting cas-
cade at a much earlier stage [38,39]. Additionally,
homologies have been observed between domains of
the Drosophila clot fibers constituent hemolectin and
domains of human clotting factors V and XIII.
Similarities in protein sequence have also been
observed between insect hemolectin and human von
Willebrand factor (vWF), a glycoprotein involved in
hemostasis, (Figure 3) [40,41].
Despite the conservation of structure and functions of
some clotting factors, greater variation in clotting cascades
and clotting factors has been observed between insects and
mammals. Drosophlia clotting cascades involve a number
of clotting factors in three clotting steps to form a hardened
Figure 3. Sequence comparison between human (h) von Willebrand factor and Drosophila (d) Hemolectin protein sequences using
emboss needle pairwise sequence alignment. Highlighted in yellow are conserved cysteine residuals. hVWF and dHemolectin are up
to 30.9% similar protein sequences. * (asterics); indicates a single, fully conserved residue,: (colon); indicates conservation between
groups of strongly similar properties, . (full stop); denotes conservation between groups of weak similar properties).
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clot. Firstly, a primary clot is formed through hemocyte
degranulation where an aggregate is formed consisting of
hemocytes, cell debris and extracellular matrix [42,43].
Secondly, the prophenoloxidase system (see: “The insect
prophenoloxidase activating (proPO) system”) and trans-
glutaminases are activated which contribute to the cross-
linking and hardening of the clot [44]. This also highlights
the link in evolution ofmelanization and clotting in insects,
a process that occurs independently in mammals. Finally,
plasmatocytes are recruited to seal the clot [45]. In
Drosophila, a number of clotting factors have been identi-
fied. Hemolectin is the most abundant protein found in the
insect clot but many other factors contribute to the forma-
tion of a stable clot [46]. Activated transglutaminase (as a
result of wounding or infection) interacts with its substrates
Fondue and Eig71Ee, causing their subsequent covalent
cross linkage and the formation of a hardened clot,
(Figure 4) [47]. Lipophorin, which is analogous to mam-
malian lipid carrrier, is also involved in the polymerisation
of the insect clot. Additionally, the activation of phenolox-
idase by the proPO system works alongside transglutami-
nase through its involvement in the final crosslinking of the
clot in addition to having a primary function in the direct
killing of pathogens through melanization [46].
Mammalian clotting systems are better understood and
more clotting factors have been identified. Firstly, primary
hemostasis in humans occurs where a platelet plug in
formed at the site of bleeding. Secondly two different path-
ways can be activated both of which lead to fibrinogen
being converted to fibrin; the extrinsic tissue factor (TF)
system or the intrinsic contact system. The contact system
involves activation of factor XII by collagen exposure in the
bleeding vessel. Subsequently, the activation of the factors
XI, IX, VIII and X takes place, respectively. Factor X (in the
presence of lipids, platelets, calcium and factor V) initates
the conversion of prothrombin to thrombin which then
converts fibrinogen to fibrin. The production of fibrin
finally stabilizes the fibrin network/clot [48,49]. TF is con-
stitutively expressed smooth muscle cells, pericytes and
fibroblasts. Upon vessel injury platelets bind to vWF. This
event then initiates the binding of TF to factor VIIa result-
ing in platelet activation via PAR1 and PAR4 receptors.
Platelet activation ultimately leads to the conversion of
prothrombin to thrombin and finally fibrinogen to fibrin,
as in the contact system (Figure 4) [50,51].
Melanization in insects and mammals
Melanins are a group of pigmented biopolymers dervived
from phenolic compounds such as tyrosine. Melanins are
believed to have evolved over 500million years ago and can
be found in both insects and mammals despite having a
different primary role in both groups. In mammals, the
production of melanin pigments is an important compo-
nent in the colouration of hair, eyes and skin but also
contributes to protection from solar radiation [52]. In
insects, melanin production plays a vital role in the innate
immune system, colouration of the exoskeleton,
Figure 4. Schematic comparison of the hemolymph/blood clotting system in insects versus mammals.
Hemolymph clotting in insects involves co-ordination between plasmatocytes, transgluatimase mediated activation of hemolectin, eig71Ee
and fondue as well as phenoxidase activation. During the mammalian blood clotting a series of enzymatic reactions result in the formation
of thrombin and subsequently the conversion of fibrinogen to fibrin. Activations of the complement cascade also feeds into mammalian
coagulation in the same way as phenoloxidase activation in insects. Similarities can be seen in both systems in that TG is homologous to
factor XIIIa. Both factors contribute to the formation of a hemolymph/fibrin network.
VIRULENCE 1629
sclerotization and healing of wounds. There are three types
of melanin in mammals; pheomelanin which are the yel-
low-red pigments found in red hair/fur/feathers, eumelanin
which are the black to brown pigments and neuromelanin
which consists of polymeric components derived from
dopamine and produced by the substantia niagra in the
brain [53,54].
The insect prophenoloxidase activating (proPO)
system
In insects melanin production depends upon the activation
of the prophenoloxidase activating (proPO) system which
is rapidly triggered upon pathogen invasion or injury to the
cuticle. Upon activation of the proPO system, a pathogen
can be killed directly through the production of toxic com-
pounds. Alternatively, phagocytosis and encapsulation of
the invading pathogen or hemolymph coagulationmay also
be induced by this system [55]. The proPO system cascade
leading to the production of melanin is catalysed by the
redox enzyme phenoloxidase. Mammalian melanin pro-
duction is also catalysed by a redox enzyme called tyrosi-
nase and this has similar activity to insect phenoloxidase
although they share little homology. These enzymes also
differ in where they are located; tyrosinase is membrane-
bound within the melanosome of mammals while pheno-
loxidase is produced by the insect hemocytes and secreted
into the hemolymph upon activation [56].
Melanization in insects involves a number of cascades
that must be carefully regulated due to the production of
toxic and reactive intermediates which may be detrimental
to the host. ProPO activation can be triggered by pathogen
associated molecular patterns (PAMP) such as bacterial
lipopolycaccharide and peptidoglycan or fungal β-1,3 glu-
can binding to their respective pathogen recognition recep-
tors. ProPO activation can also occur independently of
PAMPs such as in the case of wounding and the presence
of cells with altered apoptosis [55,57]. Activation of the
proPO system results in the induction of a serine protease
cascade but PO is activated by apolipophorin III and inhib-
ited by lyzozyme and anionic peptide-2 in G. mellonella
[58]. Consequently, the phenoloxidase activating system is
initiated when prophenoloxidase-activating enzyme is con-
verted from its inactive pro form (pro-ppA), to its active
form (ppA). PpA can catalyse the proteolytic cleavage of
prophenoloxidase (proP) to phenoloxidase (PO) (Figure 5).
Active PO is involved in hydroxylation of monophenols.
Hydoxylation is followed by the oxidation of phenols to
form quinines. Finally, quinine polymerization is catalyzed
by phenoloxidase-monophenyl-L-dopa to form melanin
[59,60]. Excluding the final step in which melanin is pro-
duced, the proPO system displays similarities to the com-
plement system of vertebrates. In both the complement
system of mammals and the proPO system of insects,
there is production of cytotoxic and opsonic components
as summarized in Figure 5 [56]. Furthermore, there is some
similarity between the sequences of insect proPO and the
mammalian complement proteins C3 and C4 [61].
Althoughmelanization is a vital component of the insect
immune system, it must be tightly regulated by specific
protease inhibitors to allow for accuratemelanin deposition
and to reduce the toxicity associated with melanin over-
production. One such example can be seen in Drosophila
where the activation of the gene spn27A results in the
production of a serpin [62]. This particular serpin functions
by inhibiting the activation of the proPO system and there-
fore melanization [55]. There has been some debate on the
role of melanization in Drosphila, however a comprehen-
sive study by Binggeli et al. (2014) outlines the importance
of PPO1 and PPO2 in dealing with Gram-positive bacteria
and fungal infection [63].
In contrast, melanization in mammals plays quite a
different role. Melanins (pheomelanin, eumelanin and
neuromelanin) are produced by mammalian melanocytes
in specific tissues including the brain, skin, hair and eyes.
Melaninization plays a particularly important role in the
skin where melanins protect the skin fromUV by absorb-
ing UVB rays and facilitates the production of Vitamin
D3.Mammalianmelanin production is a complex process
that depends upon the levels of the antioxidant glu-
tathione. At high glutathione levels, pheomelanin is pro-
ducedwhile glutathione is not required for the production
of eumelanin [64]. In insects injury or PAMP recognition
initiates melanization, while in mammals melanization is
initiated by either the hydroxylation of L-phenylalanine to
L-tyrosine or direct hydroxylation of L-tyrosine to
L-dihydroxyphenylalanine (L-DOPA), the precursor of
both eumelanin and pheomelanin. After a number of
oxidoreductions, the reaction intermediates dihydroxyin-
dole and DHI carboxylic acid are produced before being
polymerized to form eumelanin. Alternatively, pheomela-
nin is produced through the binding of dopaquinone to
cysteine or gluthione producing cysteinyldopa and glu-
tathionyldopa, respectively, before a series of reactions
that eventually yield pheomelanin [65]. Overall, insect
melanization displays more similarities to themammalian
complement system than tomammalianmelanization due
to insectmelanization and complement playing an impor-
tant role inmicrobial mediated innate immune responses,
while mammalian melanization primarily plays a role in
pigmentation and UV protection.
Antimicrobial peptides in insects and mammals
Antimicrobial peptides (AMPs) are a group of widely
expressed molecules that are produced as an early
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defence mechanism by multicellular organisms such
as plants and animals. These peptides are produced in
response to a broad spectrum of pathogens including
bacteria, viruses, fungi and parasites but have also
been found to target cancer cells [66,67]. Most of
the identified AMPs share some common character-
istics including a size of 12–50 amino acids, a net
positive charge and an amphipathic structure.
Furthermore, AMPs can be classified based on their
secondary structure. These secondary peptide struc-
tures include α-helical, β-sheets, a mixture of α-heli-
cal and β-sheet structures or extended loop structures
[68,69]. Depending on the particular AMP and its
target pathogen, AMPs can target and kill pathogens
using two distinct modes of action (Figure 6). Upon
binding the microbial membrane, AMPs may induce
cell lysis through disruption of the membrane.
Alternatively, the peptide may induce pore formation
through electrostatic interactions, allowing the AMP
to target intracellular components of the pathogen
such as DNA and RNA. Through binding intracellu-
lar proteins, the synthesis of DNA, RNA, proteins
and the cell wall integrity may be altered resulting
in cell death [70]. Additionally, AMPs have a chemo-
tactic role in mammals which links the innate and
adaptive immune response through recruiting and/or
activating immune cells including T cells, dendritic
cells and monocytes. For example human LL-37
induces chemotaxis of human neutrophils [71].
In mammals, AMPs are secreted from parts of the
body that are subject to microbial infections including
keratinocytes of the skin, the oral mucosa, gastrointest-
inal tract, lungs, eyes and the reproductive tract [72]. In
insects, AMPs are predominantly synthesized in the fat
body (equivalent to the mammalian liver) but also in
small amounts by hemocytes before being secreted into
the hemolymph [73–75]. As in mammals, the secretion
of tissue-specific AMPs may also occur in the insect gut
epithelia [66].
Lysozyme
AMPs are extremely diverse with certain AMPs being
found in particular animal species or groups while
Figure 5. Schematic diagram of the proPO-system for melanin production in insects.
PAMPs such as β-1,3 glucan, LPS and peptidoglycan amongst others bind pathogen recognition receptors such as β-1,3 glucan-binding
protein (βG-bp), lipopolysaccharide-binding protein (LPD-BP) and peptidoglycan-binding protein (PG-BP), respectively. This results in the
activation of the serine protease cascade which initates the conversion of prophenoloxidase-activating enzyme from its pro-form (pro-ppA)
to its active form (ppA). PpA then catalyzes the conversion of prophenoloxidase (proPO) to phenoloxidase (PO). PO in combination with
phenols and O2 results in the formation of quinones which polymerize to form melanin. Similarily, the alternative complement pathway
generates C3b by C3 convertase which with other proteins froms the C5 convertage. This enzyme cleaves C5 to C5a and C5b, the latter of
which recuits and assembles C6, C7, C8 and multiple C9 molecules to form a pore forming membrane attack complex which is deposited on
the microbial cell surface ultimately resulting in cell lysis.
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other AMPs may be conserved throughout different
groups of species. One such example of an AMP con-
served throughout different animal groups are lyso-
zymes. Lysozymes are cationic proteins that target and
kill Gram-positive bacteria through hydrolysing the
peptidoglycan β-(1,4) glycosidic bonds in the bacterial
cell wall [76]. Many lysozymes in insects and mammals
also display chitinase activity which contributes to their
antimicrobial function. Lysozymes are a diverse group
and can be classified into six main sub-groups based on
their activity, structure and source. These groups
include chicken-type lysozyme (c-lysozyme) which is
present in vertebrates and insects, goose-type lysozyme
(g-lysozyme) which is mainly found in vertebrates and
some molluscs, invertebrate-type lysozyme (i-lyso-
zyme), plant lysozyme, bacterial lysozyme and phage
lysozyme [77]. Lysozyme is found in the midgut and
hemocytes of insects and the neutrophils, macrophages,
monocytes, tears and saliva of mammals [78]. In mam-
mals, lysozyme is expressed constitutively while expres-
sion is usually upregulated upon pathogen entry in
insects [79]. Insect lysozymes are small proteins of
approximately 14 kDa that display both functional
and sequence similarities to mammalian lysozymes
[80]. In particular, human lysozyme is a c-lysozyme
consisting of a 130 amino acid polypeptide of approxi-
mately 14.7 kDa [81]. The G. mellonella transcriptome
possesses four c-lysozyme and one i-lysozyme homo-
logues, its protein is present in unstimulated larvae, is
augmentable during infection, possesses antifungal
activity, induces apoptosis in Candida albicans cells,
acts in synergy with apolipophorin III and possesses
immunomodulatory activity [82–86]. Upon compara-
tive analysis, the c-lysozyme of Musca domestica was
found to contain a 122-amino acid long polypeptide
with a 38% sequence identity to human lysozyme [87].
Therefore, there are both structural and functional
similarities found between insect and mammalian lyso-
zymes. Although both mammalian and insect lyso-
zymes have a role in immune defence, insect
lysozymes may also have an additional digestive role
in some insects due to its enzymatic properties in the
midgut [87]. Pepsin mediated cleavage of lysozyme
yields peptides which possess potent anti-inflammatory
action on macrophages via interactions with TLR-4
[88]. This exemplifies the pleotropic activities of and
cross talk between AMPs/proteins and the cellular
immune response.
Defensins
Defensins are an abundant group of AMPs found in
insects and mammals and are characterized by a group
of cysteine-rich cationic peptides that contain several
disulfide bridges. Defensins are also small, ranging
from 28–44 amino acids in size and display antimicro-
bial activity against a range of pathogens including
bacteria (particularly Gram-positive bacteria), fungi
and viruses [89,90]. Defensins function by targeting
Figure 6. Schematic diagram of the mechanism of action and function of antimicrobial peptides in insects and mammals.
Both insect and mammalian AMPs display direct microbicidal activity by initiating cell lysis at the cell surface or interfering with intracellular
targets. Some AMPs possess anti-biofilm activity (e.g. LL-37), inhibit protein synthesis (e.g. apidaecin) or inhibit microbial proteases (e.g.
Histatin-5). Some AMPs also possess pleotropic cell-modulatory activities such as angiogenesis, re-epithelization, chemotaxis, anti-inflam-
matory and growth effects depending on cell type.
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microbial cytoplasmic membranes and induce the for-
mation of voltage-dependent ion channels. The forma-
tion of these ion channels alters the cell’s permeability
therefore initiating the loss of cytoplasmic ions such as
potassium. Ion loss ultimately results in microbial lysis
[91,92]. In vertebrates, defensins are categorized into
three groups based on their structure; α-defensins are
present in neutrophils, macrophages and Paneth cells of
mammals, β-defensins are present in mammalian neu-
trophils and epithelial cells while θ-defensins are
believed to be exclusively present in primate neutro-
phils [93]. Interestingly, vertebrate β-defensins are
more structurally similar to insect defensins than verte-
brate α-defensins and θ-defensins, highlighting the con-
servation of defensins through evolution [66]. Human
β-defensin 2 has a similar 3-D folded shape to insect
defensin despite their differences in disulfide-bond dis-
tribution. Insect defensins, like mammalian defensins,
have six cysteine residues involved in disulfide bond
formation but are unique in that they have a protruding
α-helical segment and are linked to the c-terminal of
the β-sheet by two disulfide bridges [94–96]. In mam-
mals, the β- defensin structure consists of cysteine
residues that form three disulfide bonds from C1-C5,
C2-C4 and C3-C6 [90].
Other antibacterial peptides are more specific and
can only target either Gram-positive or Gram-negative
bacteria, such as the invertebrate defensin isolated from
Formica rufa (the red wood ant), which is active against
Gram-positive bacteria [97]. Many AMPs display anti-
fungal activity, some of which can also target bacteria,
others only have activity against fungi [98]. Lebocin B,
a proline-rich peptide from the insect Manduca sexta,
shows antibacterial and antifungal properties.
Proline-rich AMPs
Proline-rich AMPs can be isolated from mammals and
insects and share common structural and functional
characteristics. They possess unusually high amounts
of proline residues, and often contain high levels of
arginine producing a strong net positive charge and
most target Gram-negative bacteria [99,100]. In bees
such as Apis mellifera and the cicada killer bee Sphecius
speciousus, apidaecins refer to a family of small, pro-
line-rich peptides. These 18–20 residue peptides typi-
cally consist of two regions, a C-terminal conserved
region that is responsible for the antimicrobial activity
of the peptide, and an N-terminal variable region,
which plays a role in extending the antibacterial spec-
trum of the peptide as seen in other AMPs. In this
peptide, proline makes up 33% of the residues. Its
amino nitrogen is cyclised with the side chain terminal
carbon, restricting the structure of the peptide, such
that it forms a polyproline helical type II conformation,
which is an extended left handed helix with three
residues per turn. The addition of multiple arginine
residues in the conserved region creates a more posi-
tively charged molecule, possibly affecting its antibac-
terial activity [100]. In mammals, all short proline-rich
AMPs belong to the cathelicidin family of AMPs [101].
The mammalian proline-rich peptides tend to be longer
in contrast to those found in insects. PR-39 isolated
from porcine small intestine and neutrophils, is a 39
residue long antibiotic peptide, composed of 49% pro-
line and 24% arginine [102]. Similar to other Pro-
AMPs, the presence of proline inhibits the peptide
from adopting an alpha-helical conformation. Due to
this it forms a polyproline helical type II, similar to
apidaecins, but may undergo some slight conforma-
tional changes following binding to a lipid membrane
[103]. Some studies suggest that PR-39 is the mamma-
lian equivalent of apidaecins due to the similarity of
their amino acid sequence and mode of action, however
this view is still controversial [104]. Interestingly, pro-
line-rich AMP Bac7(1–35) kills MRD Pseudomonas
aeruginosa by disrupting their cell membranes, while
it mode of action on Escherichia coli and Salmonella
enterica serovar Typhimurium is primarily intracellular
[105]. Furthermore, both insect oncocin and apidaecins
have been demonstrated to bind to different regions of
bacterial ribosomes, leading to inhibition of protein
synthesis [106–108]. The fact these peptides act on
multiple cellular targets makes bacterial resistance to
their microbicidal activity difficult.
Drosophila melanogaster AMPs
Although there is conservation of some AMPs such as
defensins and lysozyme between insects and mammals
there is far more variability between the two groups. At
present over 290 AMPs have been identified in insects
therefore it may be more informative to discuss insects
AMPs in two species: Drosophila melanogaster and
Galleria mellonella, (Table 1) [109]. In addition to
defensins and lysozyme which predominantly target
Gram-positive bacteria, D. melanogaster also express
several AMPs that are not produced in mammals. For
example, cecropins, drosocin, attacins, diptericin and
maturated-pro-domain of attacin C (MPAC) are AMPs
that target bacteria (mostly Gram-negative) while dro-
somycin and metchnikowin are AMPs that mostly tar-
get fungi in Drosophila [110].
Cecropins are amphipathic α-helical AMPs of 11
amino acids in length that have the ability to target
and kill bacteria and filamentous fungi [94,111]. In
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insects, members of this family can be isolated from the
hemolymph of moths and flies following bacterial
infection [112–115]. These cecropins are 35–40 resi-
dues long, possess a C-terminal helical stretch and dis-
play a broad spectrum of activity against Gram-positive
and Gram-negative bacteria, as well as some fungi
[116]. Under aquatic solutions, these peptides typically
adopt a random coil structure, but switch to an α-
helical conformation in a hydrophobic environment.
In Gram-negative bacteria, the hydrophobic
C-terminal of cecropin interacts with the phospholipid
membrane of the bacteria leading to membrane disrup-
tion and bacterial cell death [117]. It demonstrates
antibacterial activity against multidrug resistant A. bau-
manii and P. aeruginosa, induces C. albicans apoptosis
and recently has been shown to possess immunomodu-
lary effects on macrophages [118,119]. There is evi-
dence of cecropins in bovine adrenal glands and pig
intestines, but they are more prominent in insects [80].
Metchnikowin is a proline-rich peptide consisting of
26 amino acid residues that has the ability to target
both fungi and Gram-positive bacteria [120].
Metchnikowin specifically targets pathogenic fungi of
the phylum Ascomycota such as Fusarium species. In
the case of Fusarium graminearum strains, metchniko-
win displays its fungicidal activity by targeting β (1,3)-
glucanosyltransferase Gel1, an essential enzyme in cell
wall biosynthesis. As a result, β(1,3)-glucan chain elon-
gation is inhibited, disrupting cell wall synthesis and
thus, initiating fungal cell death [121].
Attacins are glycine-rich AMPs of approximately 190
amino acids with a helical conformation and a random coil
structure. InDrosophila species four genes, namely attA, B,
C andD encode attacins [122]. Attacins kill Gram-negative
bacteria by targeting lipopolysaccharide in the membrane
resulting in an inhibition of protein synthesis. Attacinsmay
also increase the permeability of the bacterial cell by creat-
ing ion channels in the membrane bilayer, initiating cell
death [123].
Galleria mellonella AMPs
G. mellonella larvae are now widely employed to study
the virulence of a range of microbial pathogens [124–
126] and to assess the immune responses of larvae to
infection [127–130]. Their low cost, large size and ease
of use, make them an ideal model system to overcome
the disadvantages associated with mammalian testing
and to generate comparable results in a short space of
time [131]. G. mellonella produces at least 18 putative
AMPs and their humoral response to a range of bacter-
ial and fungal pathogens has been well documented in
recent years with advances in transcriptomics and pro-
teomic technologies [132,133].
Gallerimycin is a cationic 57 amino acid inducible
cysteine-rich defensins peptide with anti-filamentous
fungi activity against Metarhizium anisopliae and is indu-
cible during bacterial infection [134–136]. Gallerimycin
alone does not possess anti-bacterial activity but displays
synergistic activity with cecropin A which expands the
antimicrobial spectrum of gallerimycin by causing exten-
sive non-lytic depolarization of E. colimembrane resulting
in inhibition of growth [137].
Bioactivated galliomicin is a 43 amino acid AMP which
contains 6 cysteine residues and exhibits anti-filamentous
activity [135], is induced byC. albicans [138], physical stress
[139] and extremes (4°C and 37°C) in temperature [140],
indicating it is induced indiscriminately in times where
infection may be likely. Other invertebrate α-helical
AMPs include the moricins, isolated exclusively from the
Ledipoteran insects. Moricins are 42-residues long α-helical
peptides with 8 turns along the peptide. The N-terminal
residues (5–22) are amphipathic and responsible for bac-
terial membrane permeability, while the C-terminal resi-
dues (23–36), are hydrophobic and needed for full
antimicrobial activity [97]. Moricins are secreted as pro-
peptides under the control of (NF-kB)/Rel and GATA
transcription factors and are activated via proteolysis and
increase the permeability of bacterial and fungal mem-
branes.G.mellonellawhich has sevenmoricin-like peptides
in its transcriptomics and these are highly active against
yeasts and filamentous fungi [141]. Gloverins are glycine
rich, heat stable antibacterial polypeptides believed to bind
LPS and possibly components of the fungal cell wall. It was
previously demonstrated that E. coli induces gloverin
expression in Bombyx mori [142]. The abundance of both
moricin-like peptides and gloverins are increased early
during infection with C. albicans and A. fumigatus in G.
mellonella larvae [128,143]. Larvae may also induce the
expression/abundance of other humoral factors such as
Table 1. A comparison of the antimicrobial peptides present in insects and humans.
Drosophila melanogaster Galleria mellonella Human
Name Characteristic Name Characteristic Name Characteristic
Cecropins α helical Cecropins α helical Cathelicidin α helical
Drosomycin Cysteine rich Gallerimycin Cysteine rich Defensin Cysteine rich
Metchnikowin Proline rich Galliomicin Cysteine rich Histatin-5 Histidine rich
Attacins Glycine rich Moricin-like peptides α helical Dermcidin Anionic peptide
Drosocin Proline rich Gloverin-like peptides Glycine rich
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anionic peptide-1, Cecropin D-like peptide, hemolin,
27 kDa G. mellonella hemolymph protein, Hdd11 in
order to curtail microbial growth before activation of the
cellular immune response.With the recent release of theG.
mellonella genome, there is much opportunity to study the
role of individual humoral immune proteins/peptides dur-
ing the infection process in larvae [144].
Conclusion
The humoral component of the innate immune system of
mammals shows many similarities to the insect immune
response (Table 2). However there are also significant
differences in processes and components of each
response. The activation of NF-κB and its homologs in
mammals and insects plays a very important role in
immunity. In mammals, NF-κB is involved in production
of cytokines and co-stimulatory molecules as well as cell
survival and apoptosis signalling through the activation of
Toll-like and TNF-α signaling pathways. In contrast, in
Drosophila the NF-κB homologs (Dif, Dorsal and Relish)
are activated by Toll and IMD pathways and are directly
involved in innate humoral immune responses through
initiating the transcription of AMPs. Blood/hemolymph
clotting plays a vital role in both insect and mammalian
immunity although clotting in insects is more important
due to their open circulatory system. There are homolo-
gous clotting factors observed in both systems, particu-
larly between insect transglutaminases and human
clotting factor XIIIa. Specific clotting factors have also
been identified such as hemolectin and Fondue in
Drosophila and factors XII, XI, IX, VIII, X and V in
humans. In mammals melanization plays a role in pig-
mentation and protection of the skin from solar radiation
while in insects melanization plays a direct role in innate
humoral immunity through activation of the proPO sys-
tem by PAMPs. Defensins and lysozyme are two groups
of AMPs found in both mammals and insects and mam-
malian c-lysozyme and β-defensins display structural and
functional similarities to their insect counterparts.
Furthermore, there are a variety of AMPs unique to
particular animal groups including mammalian cathelici-
dins and insect metchnikowin, cecropin and attacins.
While there aremany significant differences between the
humoral component of the insect immune system and the
innate immune system ofmammals the similarities that are
present are sufficient to allow the use of insects as models
for studying microbial virulence. The increased use of
insects as in vivo models for studying microbial virulence
[12–14,124] or disease development [127–129,143,145] is
to be welcomed. An enhanced understanding of the simila-
rities and differences between the immune responses of
insects and mammals will increase the attractiveness of
using insects as in vivo models with a concomitant reduc-
tion in the use of mammals.
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TLR Toll-like receptor
TNFα Tumor necrosis factor alpha
UV ultraviolet
vWF Von Willebrand factor.
Acknowledgments
Gerard Sheehan is the recipient of a Maynooth University
Doctoral studentship.
Table 2. A comparison of humoral receptors, anti-microbial
peptides, cascades and enzymes in mammalian and insect
humoral immune responses.
INSECT MAMMALIAN
RECEPTORS Toll, IMD, β-1,3 glucan,
IL-1R, Calreticulin,
Hemolin, Lectins,
Hemocytin
TLRs, TNFα, β-1,3
glucan, IL-1R,
Calreticulin, C-type
lectins, Macrophage
mannose receptor
TRANSCRIPTION
FACTORS
NF-κβ, I-κβ NF-κβ, I-κβ
COAGULATION
CASCADE
Transglutaminase,
Hemolectin
Factor XIIIa, vWF
IMMUNE CASCADES Prophenoxidase
cascade
Complement cascade,
Melanization of skin
METALLOPROTEINASE
INHIBITORS
IMPI Collagenase,
Gelatinase
AM-PEPTIDES Defensins, cecropins,
moricins, gloverins,
attacins
Defensins, LL-37,
Dermcidin
AM-PROTEINS Lysozyme, Sarcotoxin Lysozyme, Histatin-5
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